Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Australian Pharmaceutical Industries Announces Regarding Revised Non-Binding Indicative Proposal from Wesfarmers

16 Sep 2021  |  10:02:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Revised Non-Binding Indicative Proposal from Wesfarmers

Australian Pharmaceutical Industries announced that it had received a non-binding indicative proposal from Wesfarmers to acquire 100% of the shares in the Company for cash consideration of $1.38 per share. This proposal was rejected by the Company Board on 29 July 2021. The Company announces that it has received a revised non-binding indicative proposal (Revised Indicative Proposal) from Wesfarmers to acquire 100% of the shares in the Company, by way of a scheme of arrangement, for cash consideration of $1.55 per share.

Please click here for full details

See more ASX300 News Announcements